Chapter 3 - The Orange Liquid
Two floors below the ER, in the windowless sub-basement of the county crime lab, Detective Sarah Lin smelled like black coffee and cigarettes.
She tapped the glass of the mass spectrometer monitor with a pen. Garrison stood behind her, his uniform shirt still damp, his eyes bloodshot from twelve hours without sleep. Through the double glass doors of the corridor, two uniformed officers guarded the elevator bank.
“The hospital’s rapid screen came back inconclusive because it wasn’t an off-the-shelf pharmaceutical,” Lin said, her raspy voice cutting through the hum of the cooling units. “It’s not insulin. It’s not rat poison. It’s not an organophosphate. It’s something Julian Mercer cooked himself.”
“Can you prove it?” Garrison asked.
Lin tapped a key on the terminal. A complex three-dimensional molecular model spun onto the screen—a dense web of carbon rings flanked by synthetic peptide chains.
“This is Mercer-9. That’s what he called it in his preliminary grant applications to the Department of Defense three years ago,” Lin said, pulling up a redacted PDF document. “Julian Mercer was trying to engineer an accelerated cell-repair agent. A synthetic neuro-peptide designed to force the brain’s glial cells into hyper-regeneration after traumatic blast injuries. A miracle drug for soldiers with blown-apart brains.”
Garrison leaned in closer, his fists clenched in his pockets. “If it’s a regenerative medicine, why is Maya dying in pediatric ICU?”
“Because the human body rejects the synthetic carrier,” Lin turned in her swivel chair, her dark eyes hollow. “The peptide works for about twenty minutes. It stimulates neural synapses at four hundred percent of normal capacity. Then the synthetic lipid shell breaks down into a secondary metabolite: fluoroacetate derivative. In plain English? It turns into molecular acid inside the liver and the brain stem.”
Garrison felt a cold knot twist in his gut. “He knew it was toxic.”
“He knew it was fatal in ninety-eight percent of animal trials,” Lin corrected grimly. “The DoD pulled his funding eighteen months ago. The FDA issued an immediate cease-and-desist on all mammalian testing. Julian was ruined. His research was about to be seized by the university creditors. Unless…”
“Unless he could prove it worked on human biology,” Garrison whispered.
“Not just any human biology,” Lin pointed to a side-by-side genetic chart. “The peptide requires a specific, extremely rare human leukocyte antigen profile to prevent immediate anaphylactic shock. An HLA-type that only appears in less than zero-point-zero-one percent of the population. Claire Mercer had that profile. And so do his twin daughters.”
Garrison felt the room tilt. The sterile air seemed suddenly hard to draw into his lungs.
“He didn’t give it to Maya to treat a disease,” Garrison said, the words tasting like copper. “He was using her as a human bioreactor.”
“The mother died eighteen months ago,” Lin said, pulling up Claire Mercer’s death certificate. “Signed off by an attending physician who was on Julian’s grant payroll. Cause of death: rapid-onset ALS with respiratory arrest. No autopsy was performed. She was cremated within forty-eight hours.”
“And Elena?” Garrison asked. “Why did he dose Maya and not Elena?”
“Elena was the control,” Lin whispered. “You can’t run an experiment without a baseline.”
The door to the lab swung open with a violent crack.
Officer Miller, a rookie from Station Three, stood in the doorway, breathing hard, his duty belt jingling.
“Vance! Lin! You need to get up to the fourth-floor administration building right now.”
Garrison straightened instantly. “What happened? Is it Maya?”
“No,” Miller swallowed hard. “Judge Holbrook just issued an emergency protective transfer order. Julian Mercer’s lawyers just served the hospital. They’re moving Elena out of child protective custody and into Julian’s private medical facility under research conservatorship. A county transport van is pulling up to the juvenile annex right now.”
May you like
Garrison didn’t run. He sprinted.
***
